News Report | October 20, 2021
HHS Proposes Testing Value-Based Payments For Medicare Part B Drugs
The federal Department of Health and Human Services (HHS) proposed testing models that use value-based payments in Medicare Part B to link payment with a medication’s clinical value. The proposal is part of a recommendation that HHS use administrative tools and push for congressional action to reform medication pricing. HHS has existing administrative tools to promote competition and reduce drug costs.
In addition to testing value-based payment for Medicare Part B medications, the proposal listed five administrative levers that HHS could implement without express approval from Congress. Additional details about the administrative levers are as follows:
<ul . . .